NCT06068179View on ClinicalTrials.gov

Graves' Disease Remission Study: MycoMeth Combo

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

October 16, 2023

Primary Completion Date

October 8, 2025

Study Completion Date

October 8, 2026

Conditions
Graves' Disease
Interventions
DRUG

Mycophenolate Mofetil, Oral, 250 Mg

Mycophenolate Mofetil, Oral, 500Mg twice daily for 12 months, combined with methimazole standard therapy

DRUG

methimazole, oral, 10mg

Methimazole 15-30mg daily initially then titrate to maintenance dose.

Trial Locations (1)

361003

RECRUITING

Xiao Fangsen, Xiamen

All Listed Sponsors
lead

The First Affiliated Hospital of Xiamen University

OTHER